Colorectal cancer
B90 – B137
- B90: An exploration of patients’ perceived control, self efficacy and involvement in self care during chemotherapy for colorectal cancer
- B91: Is bowel cancer screening (BCS) acceptable to patients? A review of the 30 day patient satisfaction questionnaire at six months
- B92: The patient experience of colorectal cancer – implications for primary care
- B93: High-risk pathological criteria and prognosis in node-negative colorectal cancer
- B94: A national perspective on the surgical management and outcomes of colorectal cancer liver metastases
- B95: English surgical colorectal cancer practice between 1998 and 2004
- B96: Variation in the operative mortality of colorectal cancer across the NHS in England
- B97: Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme
- B98: c-Src activity and NFκB-dependent anti-tumour effects of aspirin in colorectal cancer
- B99: Investigating prognostic and predictive influences of germline polymorphisms on colorectal adenoma recurrence
- B100: Investigating the potential chemopreventative activity of resveratrol sulfate metabolites
- B101: Improving the early detection of colorectal cancer: the role of MMP9
- B102: Radiation-induced adenoma multiplicity in ApcMin/+ is controlled five genetic loci
- B103: Most bowel cancer screening (BCS) colonoscopies are undertaken for weak positive Faecal Occult Blood (FOB) test results
- B104: Detection of early cancers by the Bowel cancer Screening Programme (BCSP) and analysis of the presence of underlying symptoms
- B105: The incidence and management of polyp cancers in the bowel cancer screening programme
- B106: Systemic administration of recombinant human VEGF165b inhibits tumor growth in vivo
- B107: Colorectal cancer: genetic predisposition in South Asian population in West Yorkshire region
- B108: Fine mapping on mouse chromosome 3 of a susceptibility locus to Helicobacter hepaticus induced colitis
- B109: Induction in iron transport proteins is downstream of iron mediated Wnt signalling
- B110: Impact of stem cell marker expression on liver and tumour following portal vein embolisation
- B111: Exfoliated cell lineage in stool-based colorectal cancer screening
- B112: Heat shock protein-27 predicts poor survival in rectal, but not colon cancer
- B113: Comparative analysis of supervised classification methods in predicting response to chemotherapy in colorectal cancer patients
- B114: First report of the five year results of prospective histopathology proforma reporting in the MRC CLASICC trial
- B115: Prospective assessment of the quality of surgery in the MRC CLASICC trial evidence for variation in the plane of surgery in colon cancer, local recurrence and survival
- B116: The role of the Src family kinase-ADAM17-TGFα autocrine loop in chemotherapy resistance
- B117: Lapatinib – Drug response and correlation studies in colorectal cancer cell lines
- B118: Vandetanib markedly reduces tumour burden in a dextran sodium sulphate-enhanced ApcMin/+ model of colorectal cancer
- B119: The use of cell line models to predict patient response to chemotherapy in advanced colorectal cancer
- B120: Diindolylmethane demonstrates activity in preclinical models of colorectal carcinoma both as monotherapy and in combination with AZD0530, a Src inhibitor
- B121: Anti-proliferative and pro-apoptotic activity of AZD1152-HQPA, a selective inhibitor of Aurora B kinase, in combination with oxaliplatin in a colorectal tumour model
- B122: Growth inhibitory effect of 5-aza-2’-deoxycytidine on cancer cells is independent of p16 ink4a and p14ARF
- B123: RNA interference screen of the human Wnt signaling pathway
- B124: Copy number and methylation analysis of microsatellite and chromosome stable colorectal cancers
- B125: DNA copy number assessed by high resolution array comparative genomic hybridization predicts prognosis in colorectal cancer
- B126: Synthetic lethal killing of mismatch repair deficient cells
- B127: CD24 is expressed in specific cells in intestinal epithelia and regulates apoptosis and proliferation in this tissue
- B128: The role of the HER2/HER3/PI3 Kinase survival pathway in colorectal cancer
- B129: Fish oil and corn oil in the prevention of colon cancer
- B130: KLF6 and p21 expression contribute to colonic crypt length and CRC pathogenesis
- B131: Fbw7 is a key regulator between intestinal stem cells properties and tumour development
- B132: Raf kinase inhibitor protein (RKIP) expression in colorectal cancer is associated with metastatic recurrence and reduced overall survival: from discovery to function
- B133: Epithelial-mesenchymal transition of human colorectal cancer cells is associated with reduced 15-prostaglandin dehydrogenase protein levels
- B134: Analysis of unstained human tissue using Optical Projection Tomography (OPT) and its potential for clinical diagnosis of colon polyps
- B135: Long-term outcome of the first UKCCCR randomised trial of chemo-radiation for the treatment of epidermoid anal cancer
- B136: Treatment of localized squamous cell carcinomas of the rectum by chemoradiation allows avoidance of surgery
- B137: The impact of both surgery and pre-operative radiotherapy on patients quality of life: data from the MRC CR07 / NCIC CO16 randomised clinical trial in patients with rectal cancer
